Hair-Loss Drug Stocks Emerge as Wall Street’s Next Big Bet
Investors are piling into hair-loss drug developers as Veradermics shares surge and analysts see multibillion-dollar sales potential for Cosmo’s treatment.
#Biotech
Explore MarketSpeaker's latest reporting, research, and expert analysis tagged with "biotech", collected in one continuously updated archive.
Related Posts
AstraZeneca and Bristol Myers Hold Merger Talks in Potential $400 Billion Deal
AstraZeneca and Bristol Myers Squibb have held discussions about a potential merger valued at more than $400 billion, a deal that would create one of the world’s largest pharmaceutical companies.
Enhanced Games Shares Crash 52% After Debut Event Disappoints
Enhanced Games shares plunged after the company’s first steroid-permitted sports event failed to meet expectations.
Eli Lilly to Acquire Ajax Therapeutics in Deal Worth Up to $2.3 Billion
By
Emma Clarke
• 2 mins read
Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion, strengthening its pipeline in blood cancer treatments.
Novo Nordisk Partners With OpenAI to Accelerate AI-Driven Drug Discovery
By
Emma Clarke
• 3 mins read
Novo Nordisk has partnered with OpenAI to enhance its drug discovery efforts using advanced AI tools, aiming to accelerate identification of new treatments.
Eli Lilly Strikes Up to $2.75 Billion AI Drug Deal With Insilico Medicine
By
Emma Clarke
• 2 mins read
Eli Lilly will pay up to $2.75 billion to bring AI-developed drugs from Insilico Medicine to market. The deal highlights growing momentum in AI-driven drug discovery.
Novartis Acquires Excellergy for $2 Billion in Immunology Push
By
Emma Clarke
• 2 mins read
Novartis has agreed to acquire immunology biotech Excellergy for $2 billion, marking its second major deal in a week. The move strengthens its pipeline in next-generation allergy treatments.
Leap Therapeutics Surges 170% After $50M Zcash Investment Backed by Winklevoss Capital
By
Oleg Petrenko
• 1 min read
Leap Therapeutics shares jump 170% after rebranding to Cypherpunk and investing $50M in Zcash, marking a major shift toward digital asset strategy.
Chan Zuckerberg Biohub Launches Major AI-Biology Research Initiative
By
Oleg Petrenko
• 2 mins read
The Chan Zuckerberg Biohub, founded by Mark Zuckerberg and Priscilla Chan, announced a new initiative merging artificial intelligence, biology, and computing to accelerate breakthroughs in health and disease research.
Biotech Firm BillionToOne Shares Surge 67% on $273M IPO
By
Oleg Petrenko
• 2 mins read
Molecular-diagnostics startup BillionToOne raised $273 million in an oversubscribed IPO, with shares jumping 67% at debut and valuing the company at around $4.4 billion.